Background: The aim of this prospective study was to investigate the potential influence of the fat mass and obesity-associated gene (FTO), SNP rs9939609, on body mass index (BMI) and body composition in women with severe anorexia nervosa during intensive nutrition therapy and after three years.
Methods: Twenty-five female anorexia nervosa patients (age 20.1±2.3 years, BMI 15.5±1.0 kg/m2) were treated for 12 weeks with a high-energy diet. FTO was genotyped and body composition parameters were assessed by dual-energy X-ray absorptiometry and peripheral quantitative computed tomography at baseline, after 12 weeks and at three-year follow-up.
Results: Patients gained, on average, 9.9 kg and BMI increased to 19.0±0.9 kg/m2 during intensive nutrition therapy. Fat mass increased, p<0.001, but total lean mass was stable. After three years, BMI remained stable, 19.4±3.3 kg/m2, as well as fat mass parameters and total lean mass. Muscle density decreased while the quotient fat/muscle area increased during nutrition therapy, but both then stabilized and remained stable after three years. There were no associations between FTO genotype and BMI or body composition parameters during the nutrition therapy or after three years. A tendency towards more stable BMI was observed in patients with the TT genotype and wider range in BMI for patients with the risk allele A after three years.
Conclusions: Irrespective of the FTO genotype, there was no difference in weight response during nutrition therapy, or at three-year follow-up. Hence, there is limited support for individualized therapy for anorexia nervosa based on FTO genotype.
Trial registration: Current Controlled Trials ISRCTN76310580. Date of registration: 15/01/2020. Retrospectively registered.